KHSC) clinician-scientist and Queen's researcher Dr Jagdeep Walia has generated preclinical evidence for a gene therapy approach that may be a potential treatment for GM2 gangliosidoses, also referred to as Tay-Sachs (TSD) and/or Sandhoff disease (SD).

New licence agreement between Queen’s University and Taysha Gene Therapies could lead to development of treatments for rare diseases in children

News / General / Children’s Health / Research / Discovery / Breakthrough / Pediatric Care
September 28th, 2020

FOR IMMEDIATE RELEASE
Monday, Sept. 28, 2020

KINGSTON, Ont. – Queen’s University announced that it has entered into a research collaboration and licensing agreement with Taysha Gene Therapies, Inc., for the development and commercialization of gene therapy for GM2 gangliosidoses.

The GM2 gangliosidoses are a group of degenerative/inflammatory diseases...Read more

Celebrating 175 years of caring for body, mind and spirit

News / General
September 18th, 2020

In September 1845, a notice started appearing in the Kingston Chronicle and Gazette stating that “The Hotel Dieu” on Brock Street was now open “for the reception of persons requiring Medical or Surgical assistance” with a single daily visiting hour from 9 to 10 a.m.

This...Read more